Extracutaneous tumour mass following bexarotene and interferon therapy of primary cutaneous CD30+ large cell lymphoma.
Kreuter
Alexander
A
Altmeyer
Peter
P
Gambichler
Thilo
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077610:Bexarotene; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007372:Interferons / Q000008:administration & dosage; D017730:Ki-1 Antigen; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage
D017730:Ki-1 Antigen; D013764:Tetrahydronaphthalenes; D007372:Interferons; D000077610:Bexarotene